234 related articles for article (PubMed ID: 26678309)
21. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
22. [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice].
Zhu ML; Liu J; Liu YL; Yang WJ; Luo Y; Zhuang ZJ; Jiao QB; Chen JY; Yan J; Bian DX; Ma XJ; Xun YH; Shi JP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):325-7. PubMed ID: 24645313
[TBL] [Abstract][Full Text] [Related]
23. S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet.
Mukai K; Miyagi T; Nishio K; Yokoyama Y; Yoshioka T; Saito Y; Tanaka S; Shigekawa M; Nawa T; Hikita H; Sakamori R; Yoshihara H; Imai Y; Hiramatsu N; Tatsumi T; Takehara T
J Immunol; 2016 Jan; 196(1):395-406. PubMed ID: 26608915
[TBL] [Abstract][Full Text] [Related]
24. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
[TBL] [Abstract][Full Text] [Related]
25. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.
Farrell GC; Mridha AR; Yeh MM; Arsov T; Van Rooyen DM; Brooling J; Nguyen T; Heydet D; Delghingaro-Augusto V; Nolan CJ; Shackel NA; McLennan SV; Teoh NC; Larter CZ
Liver Int; 2014 Aug; 34(7):1084-93. PubMed ID: 24107103
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
[TBL] [Abstract][Full Text] [Related]
27. Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
Heintz MM; McRee R; Kumar R; Baldwin WS
PLoS One; 2020; 15(3):e0229896. PubMed ID: 32155178
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
29. Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
Xia Y; Andersson E; Caputo M; Cansby E; Sedda F; Font-Gironès F; Ruud J; Kurhe Y; Hallberg B; Marschall HU; Asterholm IW; Romeo S; Blüher M; Mahlapuu M
Mol Med; 2023 Oct; 29(1):138. PubMed ID: 37864157
[TBL] [Abstract][Full Text] [Related]
30. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.
Onofrio LI; Arocena AR; Paroli AF; Cabalén ME; Andrada MC; Cano RC; Gea S
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003464. PubMed ID: 25668433
[TBL] [Abstract][Full Text] [Related]
31. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
32. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.
Sansbury BE; Cummins TD; Tang Y; Hellmann J; Holden CR; Harbeson MA; Chen Y; Patel RP; Spite M; Bhatnagar A; Hill BG
Circ Res; 2012 Oct; 111(9):1176-89. PubMed ID: 22896587
[TBL] [Abstract][Full Text] [Related]
35. ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity.
Bauters D; Spincemaille P; Geys L; Cassiman D; Vermeersch P; Bedossa P; Scroyen I; Lijnen HR
Liver Int; 2016 Dec; 36(12):1848-1859. PubMed ID: 27254774
[TBL] [Abstract][Full Text] [Related]
36. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
37. DHA supplementation prevent the progression of NASH via GPR120 signaling.
Nakamoto K; Shimada K; Harada S; Morimoto Y; Hirasawa A; Tokuyama S
Eur J Pharmacol; 2018 Feb; 820():31-38. PubMed ID: 29221950
[TBL] [Abstract][Full Text] [Related]
38. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
[TBL] [Abstract][Full Text] [Related]
39. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
Sim WC; Lee W; Sim H; Lee KY; Jung SH; Choi YJ; Kim HY; Kang KW; Lee JY; Choi YJ; Kim SK; Jun DW; Kim W; Lee BH
Metabolism; 2020 Jan; 102():154000. PubMed ID: 31678070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
